ATI Hematologic System Exam With Verified
Solutions
pt is about to begin iron dextran (INFeD). When administering the drug IM, the HCP should take which
of the following actions?
1. Monitor BP
** Iron dextran can cause hypotension and hypersensitivity rxns
2. Administer a test dose
** to determine hypersensitivity and allow 1 hr for identifying b/c Iron dextran can cause
hypersensitivity rxn
3.Have epinephrine available
** and monitor for skin rash, fever, and chills
4.Use Z-track technique
** to make sure to deposit it deep into the buttocks. Superficial injection can cause abscesses and
brown discoloration of the skin
HCP caring for pt who is about to begin taking altepase (Activase) to treat acute myocardial infarction.
The HCP should understand the drug is most effect when the pt receives it
within 3 hr of symptom onset.
pt about to take filgrastim (Neupogen) to treat neutropenia. The HCP should assess the pt for which
of the following adverse effects?
Enlarged spleen
** with long term use, filgrastim, a leukopoietic growth factor, can cause an enlarged spleen. HCP
should tell pt taking the drug to monitor and report abd pain or fullness.
HCP is preparing to admin filgrastim (Neupogen) to a pt. The pt lab results indicate that the pt has a
WBC count of 12,000/mm 3. Which of the following actions should the HCP take?
Clarify the prescription with the provider
HCP administers eopoetin alfa (Epogen) SC to a pt who has renal failure. The HCP should monitor the
pt for which of the following adverse effects?
Hypertension
** Epoetin alfa, an erythropoietic growth factor, can cause hypertension. The HCP should monitor BP
and regulate it prior to initiating epoetin alfa; then monitor it during. For elevations, recommend a
reduced dosage or anti-hypertensive drug
pt is baout ot begin taking oprelvekin (Neumega). The HCP should explain to the pt tha the drug has
which of the following effects?
Increases platelet production
** Oprelvekin, a thrombopoietic growth factor, increases platelet production. It treats
thrombocytopenia that is associated with myelosuppression.
pt is about to begin taking warfarin (Coumadin). The HCP should caution the pt about taking which of
the following OTC drugs?
Ibuprofen (Motrin)
Solutions
pt is about to begin iron dextran (INFeD). When administering the drug IM, the HCP should take which
of the following actions?
1. Monitor BP
** Iron dextran can cause hypotension and hypersensitivity rxns
2. Administer a test dose
** to determine hypersensitivity and allow 1 hr for identifying b/c Iron dextran can cause
hypersensitivity rxn
3.Have epinephrine available
** and monitor for skin rash, fever, and chills
4.Use Z-track technique
** to make sure to deposit it deep into the buttocks. Superficial injection can cause abscesses and
brown discoloration of the skin
HCP caring for pt who is about to begin taking altepase (Activase) to treat acute myocardial infarction.
The HCP should understand the drug is most effect when the pt receives it
within 3 hr of symptom onset.
pt about to take filgrastim (Neupogen) to treat neutropenia. The HCP should assess the pt for which
of the following adverse effects?
Enlarged spleen
** with long term use, filgrastim, a leukopoietic growth factor, can cause an enlarged spleen. HCP
should tell pt taking the drug to monitor and report abd pain or fullness.
HCP is preparing to admin filgrastim (Neupogen) to a pt. The pt lab results indicate that the pt has a
WBC count of 12,000/mm 3. Which of the following actions should the HCP take?
Clarify the prescription with the provider
HCP administers eopoetin alfa (Epogen) SC to a pt who has renal failure. The HCP should monitor the
pt for which of the following adverse effects?
Hypertension
** Epoetin alfa, an erythropoietic growth factor, can cause hypertension. The HCP should monitor BP
and regulate it prior to initiating epoetin alfa; then monitor it during. For elevations, recommend a
reduced dosage or anti-hypertensive drug
pt is baout ot begin taking oprelvekin (Neumega). The HCP should explain to the pt tha the drug has
which of the following effects?
Increases platelet production
** Oprelvekin, a thrombopoietic growth factor, increases platelet production. It treats
thrombocytopenia that is associated with myelosuppression.
pt is about to begin taking warfarin (Coumadin). The HCP should caution the pt about taking which of
the following OTC drugs?
Ibuprofen (Motrin)
